A presentation given by Dr. Janice Mann at the 40th Annual Dalhousie February Refresher on Therapeutics, February 20, 2014.
Citation preview
1.Reliable Information for the Skeptical Family Doctor
Presentation by Dr. Janice Mann February 20th 2014 Dal
Refresher
2. Disclosure: I am an employee of CADTH I am a physician, not
currently practicing I HTA 3. How Did We Get Here? At FMF 2012: Dr.
Mike Allan (AB) at his plenary address urged family doctors to be
skeptical of their sources of information He pointed to CADTH as
one reliable source of independent, balanced evidence and
encouraged attendees to seek out this kind of information But: Most
family physicians are not familiar with CADTH or our work in HTA
How I got here is another story 4. What is HTA? 5. What is a health
technology? Pharmaceuticals (drugs, blood products, vaccines)
Diagnostics Medical, dental, surgical devices and procedures 6.
Health Technology Assessment Systematic evaluation of the evidence
on the properties, effects, and/or impacts of health care
technology 7. CADTH An independent, not-for-profit producer and
broker of health technology assessments. Health care
decision-makers rely on our work to make evidence-informed policy
and practice decisions about drugs and other health technologies.
8. Other HTA Producers in Canada INESSS (formerly AETMIS) Quebec
www.inesss.qc.ca/ Health Technology Assessment & Innovation
(HTAI) Alberta Health Alberta www.albertahealthservi
ces.ca/4122.asp Centre for Evaluation of Medicines Ontario
www.thecem.net/ Centre for Health Economics and Policy Analysis
(CHEPA) Ontario www.chepa.org/ Centre for Health Services and
Policy Research British Columbia www.chspr.ubc.ca/ Institute for
Health Economics (IHE) Alberta www.ihe.ca/ Institute for Clinical
Evaluative Sciences (ICES) Ontario www.ices.on.ca/ 9. Other HTA
Producers in Canada (cont) Ontario Health Technology Advisory
Committee Ontario www.hqontario.ca/evide nce/publications-and-
ohtac-recommendations The Technology Assessment Unit of the McGill
University Health Centre Quebec www.mcgill.ca/tau/ The Therapeutics
Initiative. Evidence Based Drug Therapy Ontario www.ti.ubc.ca/
Toronto Health Economics and Technology Assessment (THETA) Ontario
http://theta.utoronto.ca/ home Programs for Assessment of
Technology in Health (PATH) Ontario www.path- hta.ca/Home.aspx 10.
Why use HTA Evidence in Clinical Practice? Rigorous Balanced
Relevant Synthesis of large volume of research Freely available
Positive experience of family physicians and primary care
clinicians who have used HTA in practice You changed my practice
11. How to use HTA Evidence in Practice HTA provides the EVIDENCE
piece to the decision- making puzzle. Only you can make the best
decision for your patient based on the evidence as well as your
clinical experience, clinical judgment, and knowledge of your
patient. 12. How can I find HTA evidence to use in my practice? 13.
On the Web www.cadth.ca or www.acmts.ca For Clot and Stroke
Prevention: www.cadth.ca/clots For Evidence on Lab Tests:
www.cadth.ca/labtests For rapid evidence reviews on clinical health
technology questions: www.cadth.ca/RapidResponse www.cmaj.ca True
or False Quizzes Sign up for the CADTH E-alert:
https://secure.cadth.ca/en/subscribe 14. www.cmaj.ca True or False
Statements based on HTA evidence from CADTH (bottom right corner of
CMAJ homepage) True and False Archives:
http://www.cmaj.ca/site/misc/poll_ archives.xhtml 15. Via Social
Media @CADTH_ACMTS http://www.linkedin.com/company/canad
ian-agency-for-drugs-and-technologies- in-health
http://www.youtube.com/user/CADTHACMTS
http://www.slideshare.net/CADTH-ACMTS 16. Get to Know Us Lisa
Farrell Nova Scotia [email protected] Stephanie Smith New Brunswick
[email protected] Joyce Thompson Prince Edward Island
[email protected] Sheila Tucker Newfoundland and Labrador
[email protected] Janice Mann Knowledge Mobilization
[email protected] 17. Attend our Symposium 18. Using HTA evidence in
your practice 19. This tool helps to inform prescribing decisions
when the decision to start anticoagulation has been made. It
includes key research findings, information about warfarin and the
new oral anticoagulants (NOACs), and a warfarin/NOAC comparison
chart. http://clots.cadth.c a/en/tools-and- resources/publicati
on/6 20. Rapid Response Reports Example: Fluconazole Administration
for the Treatment of Ductal Yeast Infections: Clinical
Effectiveness and Safety Research Questions: 1. What is the
clinical evidence for the effectiveness of six-week fluconazole
administration for the treatment of ductal yeast infections in
breastfeeding mothers? 2. What is the short- and long-term safety
of six-week fluconazole administration for the treatment of ductal
yeast infections in breastfeeding mothers? 21. Using Evidence from
Rapid Response in Practice Results: No evidence found Putting the
results into clinical practice: Dear Patient Letter Next steps:
Patient and provider info pamphlet 22. How can I get involved with
HTA? Provide feedback on CADTH research and products. Provide
informal input as we develop new projects. Become a member of a
CADTH committee. Connect with HTA producers or users in your area.
Submit a request for a Rapid Response report* 23. [email protected]
@JustSayIt_MD @CADTH_ACMTS www.cadth.ca
